

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosome assembly (GO:0042255) | 5.04866672 |
| 2 | proteasome assembly (GO:0043248) | 4.68102039 |
| 3 | mitotic sister chromatid cohesion (GO:0007064) | 4.12378389 |
| 4 | regulation of podosome assembly (GO:0071801) | 4.07823298 |
| 5 | negative regulation of B cell apoptotic process (GO:0002903) | 3.69789911 |
| 6 | lactate metabolic process (GO:0006089) | 3.65155735 |
| 7 | tRNA aminoacylation for protein translation (GO:0006418) | 3.63582208 |
| 8 | transcription from mitochondrial promoter (GO:0006390) | 3.59146393 |
| 9 | amino acid activation (GO:0043038) | 3.58257163 |
| 10 | tRNA aminoacylation (GO:0043039) | 3.58257163 |
| 11 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.55280784 |
| 12 | maturation of 5.8S rRNA (GO:0000460) | 3.50884073 |
| 13 | purine nucleobase biosynthetic process (GO:0009113) | 3.49311418 |
| 14 | synapsis (GO:0007129) | 3.44652791 |
| 15 | DNA strand elongation (GO:0022616) | 3.42043844 |
| 16 | negative regulation of histone acetylation (GO:0035067) | 3.42023488 |
| 17 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.32702268 |
| 18 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.31861936 |
| 19 | IMP biosynthetic process (GO:0006188) | 3.27222364 |
| 20 | regulation of B cell apoptotic process (GO:0002902) | 3.26754072 |
| 21 | mitochondrial RNA metabolic process (GO:0000959) | 3.24624157 |
| 22 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.24377108 |
| 23 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.23683205 |
| 24 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.20772059 |
| 25 | ribosome biogenesis (GO:0042254) | 3.15983666 |
| 26 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.15930235 |
| 27 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.15295453 |
| 28 | non-recombinational repair (GO:0000726) | 3.15295453 |
| 29 | mitotic metaphase plate congression (GO:0007080) | 3.13781967 |
| 30 | rRNA methylation (GO:0031167) | 3.12939911 |
| 31 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.12369509 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.10795411 |
| 33 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.09750647 |
| 34 | establishment of integrated proviral latency (GO:0075713) | 3.09505585 |
| 35 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.08977935 |
| 36 | negative regulation of phagocytosis (GO:0050765) | 3.08007242 |
| 37 | dendritic cell chemotaxis (GO:0002407) | 3.07027663 |
| 38 | nucleobase biosynthetic process (GO:0046112) | 3.06991278 |
| 39 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.06716174 |
| 40 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.06716174 |
| 41 | isotype switching (GO:0045190) | 3.06716174 |
| 42 | rRNA modification (GO:0000154) | 3.06321922 |
| 43 | DNA replication initiation (GO:0006270) | 3.06077938 |
| 44 | spindle checkpoint (GO:0031577) | 3.05587673 |
| 45 | negative regulation of ligase activity (GO:0051352) | 3.05244771 |
| 46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.05244771 |
| 47 | negative regulation of protein acetylation (GO:1901984) | 3.04194399 |
| 48 | cullin deneddylation (GO:0010388) | 3.03350812 |
| 49 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 2.97756115 |
| 50 | COPI coating of Golgi vesicle (GO:0048205) | 2.96528417 |
| 51 | Golgi transport vesicle coating (GO:0048200) | 2.96528417 |
| 52 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.94554123 |
| 53 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.93136485 |
| 54 | regulation of spindle organization (GO:0090224) | 2.93091042 |
| 55 | protein deneddylation (GO:0000338) | 2.92527956 |
| 56 | mitotic spindle checkpoint (GO:0071174) | 2.91857921 |
| 57 | IMP metabolic process (GO:0046040) | 2.88830075 |
| 58 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.88592703 |
| 59 | regulation of DNA endoreduplication (GO:0032875) | 2.87635142 |
| 60 | hepatocyte apoptotic process (GO:0097284) | 2.86651196 |
| 61 | regulation of translational termination (GO:0006449) | 2.85420700 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.83400065 |
| 63 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.83022104 |
| 64 | positive regulation of ligase activity (GO:0051351) | 2.82968832 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 2.81137917 |
| 66 | sister chromatid cohesion (GO:0007062) | 2.79963531 |
| 67 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.79758113 |
| 68 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.79758113 |
| 69 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78721050 |
| 70 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.78691781 |
| 71 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.78691781 |
| 72 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.78691781 |
| 73 | DNA deamination (GO:0045006) | 2.78680904 |
| 74 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.78540001 |
| 75 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.78540001 |
| 76 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.78407506 |
| 77 | nuclear envelope organization (GO:0006998) | 2.78217948 |
| 78 | regulation of chromosome segregation (GO:0051983) | 2.76114396 |
| 79 | mitochondrial DNA metabolic process (GO:0032042) | 2.75864243 |
| 80 | spliceosomal snRNP assembly (GO:0000387) | 2.75372761 |
| 81 | positive regulation of interferon-beta production (GO:0032728) | 2.73760073 |
| 82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.73561513 |
| 83 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.73561513 |
| 84 | protein localization to kinetochore (GO:0034501) | 2.72373268 |
| 85 | regulation of fibroblast apoptotic process (GO:2000269) | 2.72209933 |
| 86 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.72074792 |
| 87 | cell cycle G1/S phase transition (GO:0044843) | 2.72074792 |
| 88 | histone H2A acetylation (GO:0043968) | 2.70065784 |
| 89 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.69667490 |
| 90 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.69473329 |
| 91 | DNA unwinding involved in DNA replication (GO:0006268) | 2.69457452 |
| 92 | regulation of ligase activity (GO:0051340) | 2.69309109 |
| 93 | regulation of translation in response to stress (GO:0043555) | 2.69149605 |
| 94 | regulation of interferon-alpha production (GO:0032647) | 2.67721916 |
| 95 | COPII vesicle coating (GO:0048208) | 2.67456619 |
| 96 | negative regulation of chromosome segregation (GO:0051985) | 2.65286986 |
| 97 | ventricular cardiac muscle cell development (GO:0055015) | 2.63897165 |
| 98 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.63837566 |
| 99 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.63837566 |
| 100 | protein complex localization (GO:0031503) | 2.63421381 |
| 101 | negative regulation of sister chromatid segregation (GO:0033046) | 2.63420936 |
| 102 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.63420936 |
| 103 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.63420936 |
| 104 | negative regulation of mast cell activation (GO:0033004) | 2.60703936 |
| 105 | establishment of chromosome localization (GO:0051303) | 2.58446848 |
| 106 | dendritic cell migration (GO:0036336) | 2.57896806 |
| 107 | metaphase plate congression (GO:0051310) | 2.56124234 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.55499212 |
| 109 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.55441409 |
| 110 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55441409 |
| 111 | modulation by symbiont of host immune response (GO:0052553) | 2.55441409 |
| 112 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55441409 |
| 113 | modulation by symbiont of host defense response (GO:0052031) | 2.55441409 |
| 114 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55441409 |
| 115 | leukocyte aggregation (GO:0070486) | 2.55092920 |
| 116 | mitotic chromosome condensation (GO:0007076) | 2.52367829 |
| 117 | protein localization to chromosome, centromeric region (GO:0071459) | 2.51990258 |
| 118 | nuclear pore complex assembly (GO:0051292) | 2.50760517 |
| 119 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.50273496 |
| 120 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49987072 |
| 121 | positive regulation of antigen processing and presentation (GO:0002579) | 2.49885407 |
| 122 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.49593583 |
| 123 | regulation of mitotic spindle organization (GO:0060236) | 2.47640127 |
| 124 | natural killer cell mediated immunity (GO:0002228) | 2.47191126 |
| 125 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.47191126 |
| 126 | DNA replication checkpoint (GO:0000076) | 2.46850761 |
| 127 | regulation of response to interferon-gamma (GO:0060330) | 2.42920746 |
| 128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.38988691 |
| 129 | mitotic nuclear envelope disassembly (GO:0007077) | 2.38450589 |
| 130 | pore complex assembly (GO:0046931) | 2.37894631 |
| 131 | nuclear pore organization (GO:0006999) | 2.34973021 |
| 132 | immunoglobulin mediated immune response (GO:0016064) | 2.34347367 |
| 133 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.34196360 |
| 134 | positive regulation of organelle assembly (GO:1902117) | 2.29432513 |
| 135 | reactive oxygen species biosynthetic process (GO:1903409) | 2.26788212 |
| 136 | regulation of interferon-beta production (GO:0032648) | 2.25364187 |
| 137 | chromatin assembly (GO:0031497) | 2.24986974 |
| 138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.24487249 |
| 139 | histone-serine phosphorylation (GO:0035404) | 2.23355644 |
| 140 | regulation of RIG-I signaling pathway (GO:0039535) | 2.23262487 |
| 141 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.21837800 |
| 142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.21837800 |
| 143 | regulation of activation of Janus kinase activity (GO:0010533) | 2.19053834 |
| 144 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.17979912 |
| 145 | respiratory burst (GO:0045730) | 2.17850412 |
| 146 | response to peptidoglycan (GO:0032494) | 2.16154277 |
| 147 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.16066751 |
| 148 | T cell apoptotic process (GO:0070231) | 2.14718125 |
| 149 | telomere maintenance via recombination (GO:0000722) | 2.14470441 |
| 150 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.12730344 |
| 151 | regulation of antigen processing and presentation (GO:0002577) | 2.11975858 |
| 152 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.11519814 |
| 153 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.10770437 |
| 154 | cellular response to type I interferon (GO:0071357) | 2.10413027 |
| 155 | type I interferon signaling pathway (GO:0060337) | 2.10413027 |
| 156 | myeloid dendritic cell activation (GO:0001773) | 2.10237058 |
| 157 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.10003460 |
| 158 | response to type I interferon (GO:0034340) | 2.09998512 |
| 159 | nuclear envelope disassembly (GO:0051081) | 2.09753846 |
| 160 | membrane disassembly (GO:0030397) | 2.09753846 |
| 161 | neutrophil activation (GO:0042119) | 2.09711337 |
| 162 | mitotic sister chromatid segregation (GO:0000070) | 2.09305911 |
| 163 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.08914124 |
| 164 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.08098509 |
| 165 | positive regulation of chromosome segregation (GO:0051984) | 2.05792373 |
| 166 | granulocyte activation (GO:0036230) | 2.05595666 |
| 167 | NIK/NF-kappaB signaling (GO:0038061) | 2.05386377 |
| 168 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.03023548 |
| 169 | mitotic G2/M transition checkpoint (GO:0044818) | 2.02990310 |
| 170 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.02312808 |
| 171 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.01455285 |
| 172 | detection of molecule of bacterial origin (GO:0032490) | 2.00892217 |
| 173 | regulation of exit from mitosis (GO:0007096) | 2.00528915 |
| 174 | positive regulation of isotype switching (GO:0045830) | 1.99755342 |
| 175 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 1.99577147 |
| 176 | sequestering of actin monomers (GO:0042989) | 1.99555732 |
| 177 | sister chromatid segregation (GO:0000819) | 1.99427915 |
| 178 | CENP-A containing nucleosome assembly (GO:0034080) | 1.98566230 |
| 179 | DNA strand elongation involved in DNA replication (GO:0006271) | 1.98351202 |
| 180 | kinetochore organization (GO:0051383) | 1.98345103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.03212427 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.51023904 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.39322649 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.33761935 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86533315 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.61490650 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.52635851 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.48734923 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.47359976 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.40308260 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.31961035 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.23891224 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.21656876 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.21129077 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18928128 |
| 16 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13013760 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10912767 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.03870555 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.02857444 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.02037114 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.00421119 |
| 22 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00393192 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99188944 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.99042464 |
| 25 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.98541964 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94754321 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89060852 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88960943 |
| 29 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.86934100 |
| 30 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86681232 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86593898 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86293430 |
| 33 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.85302902 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84300597 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.83723735 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80667880 |
| 37 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.77749922 |
| 38 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.75136147 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.75019296 |
| 40 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.72893184 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69962992 |
| 42 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.68794174 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68622404 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68396069 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63563798 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62907270 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.60943658 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58587986 |
| 49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.53435032 |
| 50 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51638879 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47571567 |
| 52 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.46975144 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46222518 |
| 54 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.45651350 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42585517 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42243807 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41473774 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.39248317 |
| 59 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38819213 |
| 60 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37565162 |
| 61 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35559250 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35461922 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.35369156 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.34903220 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34722539 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.34019577 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32831598 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32320545 |
| 69 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32262870 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29128335 |
| 71 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29058451 |
| 72 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.28403828 |
| 73 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27745520 |
| 74 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26649761 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.24216174 |
| 76 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23551953 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23251909 |
| 78 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.22009267 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21974390 |
| 80 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21521469 |
| 81 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.19635859 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.18754669 |
| 83 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18724379 |
| 84 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18034804 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17797766 |
| 86 | * MAF_26560356_Chip-Seq_TH1_Human | 1.15938316 |
| 87 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15428704 |
| 88 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15036558 |
| 89 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.14381861 |
| 90 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14271178 |
| 91 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14231215 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.13680258 |
| 93 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12783626 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11721520 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11477771 |
| 96 | MYC_22102868_ChIP-Seq_BL_Human | 1.10831291 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10491121 |
| 98 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10466571 |
| 99 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10415019 |
| 100 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.10273628 |
| 101 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09016792 |
| 102 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05213816 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04904521 |
| 104 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04765252 |
| 105 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04748899 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03408236 |
| 107 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.03042396 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02743715 |
| 109 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02042815 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01235795 |
| 111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00858384 |
| 112 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00204569 |
| 113 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00118444 |
| 114 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99817726 |
| 115 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99746151 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99595676 |
| 117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99330335 |
| 118 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.99202110 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98391996 |
| 120 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97875845 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96923484 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95970744 |
| 123 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95549648 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95051723 |
| 125 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94458153 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93967643 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93923340 |
| 128 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93811345 |
| 129 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93509007 |
| 130 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91843195 |
| 131 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91543236 |
| 132 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91484316 |
| 133 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91368495 |
| 134 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.91281836 |
| 135 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90374330 |
| 136 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87904058 |
| 137 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87414121 |
| 138 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.86605940 |
| 139 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.83972073 |
| 140 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83102056 |
| 141 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.82412022 |
| 142 | EWS_26573619_Chip-Seq_HEK293_Human | 0.81345721 |
| 143 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.80506888 |
| 144 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.79442599 |
| 145 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.78877738 |
| 146 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.77731842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.18204964 |
| 2 | MP0000372_irregular_coat_pigmentation | 2.79287368 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.77585385 |
| 4 | MP0003950_abnormal_plasma_membrane | 2.71515321 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.48588873 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.30912824 |
| 7 | MP0003941_abnormal_skin_development | 2.25256894 |
| 8 | * MP0008007_abnormal_cellular_replicative | 2.22576472 |
| 9 | MP0003718_maternal_effect | 2.21590893 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.05812475 |
| 11 | MP0010307_abnormal_tumor_latency | 2.01567412 |
| 12 | MP0004233_abnormal_muscle_weight | 1.97199679 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 1.95467154 |
| 14 | MP0009785_altered_susceptibility_to | 1.93542114 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 1.92676277 |
| 16 | MP0003436_decreased_susceptibility_to | 1.91942430 |
| 17 | MP0003077_abnormal_cell_cycle | 1.90573606 |
| 18 | MP0010094_abnormal_chromosome_stability | 1.90198354 |
| 19 | MP0006054_spinal_hemorrhage | 1.80889898 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 1.76423812 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.76423812 |
| 22 | MP0002419_abnormal_innate_immunity | 1.76197315 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.75080177 |
| 24 | MP0005671_abnormal_response_to | 1.72320445 |
| 25 | MP0005367_renal/urinary_system_phenotyp | 1.71651513 |
| 26 | MP0000516_abnormal_urinary_system | 1.71651513 |
| 27 | MP0002938_white_spotting | 1.70226213 |
| 28 | MP0008057_abnormal_DNA_replication | 1.69887723 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.67966225 |
| 30 | MP0009697_abnormal_copulation | 1.65708781 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.62953376 |
| 32 | MP0003724_increased_susceptibility_to | 1.61432370 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.58785621 |
| 34 | MP0005387_immune_system_phenotype | 1.56550620 |
| 35 | MP0001790_abnormal_immune_system | 1.56550620 |
| 36 | MP0000685_abnormal_immune_system | 1.55531287 |
| 37 | MP0008058_abnormal_DNA_repair | 1.53802038 |
| 38 | MP0003828_pulmonary_edema | 1.53409587 |
| 39 | MP0005025_abnormal_response_to | 1.52897166 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.52111193 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.52069136 |
| 42 | MP0000749_muscle_degeneration | 1.51422585 |
| 43 | MP0002723_abnormal_immune_serum | 1.48775192 |
| 44 | MP0002102_abnormal_ear_morphology | 1.44205031 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.44160234 |
| 46 | MP0003786_premature_aging | 1.42923772 |
| 47 | MP0001800_abnormal_humoral_immune | 1.42897318 |
| 48 | MP0002405_respiratory_system_inflammati | 1.40530250 |
| 49 | MP0003303_peritoneal_inflammation | 1.39510306 |
| 50 | MP0001819_abnormal_immune_cell | 1.39497891 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.39076681 |
| 52 | MP0005408_hypopigmentation | 1.38454104 |
| 53 | MP0001661_extended_life_span | 1.36197710 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.35023972 |
| 55 | MP0002398_abnormal_bone_marrow | 1.34385076 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.34221228 |
| 57 | MP0000358_abnormal_cell_content/ | 1.33422615 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.33165210 |
| 59 | * MP0001697_abnormal_embryo_size | 1.31887515 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.31835518 |
| 61 | MP0004272_abnormal_basement_membrane | 1.31779314 |
| 62 | MP0002084_abnormal_developmental_patter | 1.30759819 |
| 63 | MP0000858_altered_metastatic_potential | 1.29081174 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.25482282 |
| 65 | MP0009278_abnormal_bone_marrow | 1.25338618 |
| 66 | * MP0002080_prenatal_lethality | 1.24829188 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.24758857 |
| 68 | MP0006082_CNS_inflammation | 1.23860282 |
| 69 | * MP0002085_abnormal_embryonic_tissue | 1.23777390 |
| 70 | MP0003186_abnormal_redox_activity | 1.23405033 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.20504891 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.19302918 |
| 73 | MP0005171_absent_coat_pigmentation | 1.18634760 |
| 74 | MP0000716_abnormal_immune_system | 1.18433725 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.16804686 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.16645960 |
| 77 | MP0003566_abnormal_cell_adhesion | 1.16143611 |
| 78 | MP0002429_abnormal_blood_cell | 1.14589027 |
| 79 | MP0002006_tumorigenesis | 1.14112259 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 1.13259245 |
| 81 | MP0002722_abnormal_immune_system | 1.11455198 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.11143680 |
| 83 | MP0005058_abnormal_lysosome_morphology | 1.10087660 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 1.09854788 |
| 85 | MP0002254_reproductive_system_inflammat | 1.09488953 |
| 86 | MP0005023_abnormal_wound_healing | 1.09477922 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 1.07625034 |
| 88 | MP0003937_abnormal_limbs/digits/tail_de | 1.07609406 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 1.07229450 |
| 90 | MP0005257_abnormal_intraocular_pressure | 1.06507239 |
| 91 | MP0003448_altered_tumor_morphology | 1.06443666 |
| 92 | MP0005451_abnormal_body_composition | 1.06304156 |
| 93 | MP0009840_abnormal_foam_cell | 1.05696134 |
| 94 | MP0000490_abnormal_crypts_of | 1.05342329 |
| 95 | MP0005623_abnormal_meninges_morphology | 1.05209328 |
| 96 | MP0001542_abnormal_bone_strength | 1.04896931 |
| 97 | MP0003763_abnormal_thymus_physiology | 1.04309757 |
| 98 | * MP0000350_abnormal_cell_proliferation | 1.03257412 |
| 99 | MP0000371_diluted_coat_color | 1.03066653 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 1.01876487 |
| 101 | MP0003300_gastrointestinal_ulcer | 1.01079103 |
| 102 | MP0001853_heart_inflammation | 1.00674947 |
| 103 | MP0002269_muscular_atrophy | 1.00197607 |
| 104 | MP0003755_abnormal_palate_morphology | 0.99176244 |
| 105 | MP0005621_abnormal_cell_physiology | 0.99052098 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.98909410 |
| 107 | MP0005330_cardiomyopathy | 0.98570651 |
| 108 | MP0005395_other_phenotype | 0.98245805 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.97251749 |
| 110 | MP0009703_decreased_birth_body | 0.96004368 |
| 111 | MP0005384_cellular_phenotype | 0.95812203 |
| 112 | MP0001730_embryonic_growth_arrest | 0.94377378 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93699176 |
| 114 | MP0002160_abnormal_reproductive_system | 0.92936489 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.92561844 |
| 116 | MP0008469_abnormal_protein_level | 0.91966753 |
| 117 | MP0008260_abnormal_autophagy | 0.91766234 |
| 118 | MP0000343_altered_response_to | 0.89456641 |
| 119 | MP0002210_abnormal_sex_determination | 0.88515502 |
| 120 | MP0009672_abnormal_birth_weight | 0.88273498 |
| 121 | MP0002019_abnormal_tumor_incidence | 0.87270295 |
| 122 | MP0003705_abnormal_hypodermis_morpholog | 0.87213468 |
| 123 | MP0001929_abnormal_gametogenesis | 0.86744268 |
| 124 | * MP0002088_abnormal_embryonic_growth/wei | 0.85995670 |
| 125 | * MP0003984_embryonic_growth_retardation | 0.85767728 |
| 126 | MP0004947_skin_inflammation | 0.85560254 |
| 127 | MP0005390_skeleton_phenotype | 0.84815839 |
| 128 | MP0002933_joint_inflammation | 0.84515804 |
| 129 | MP0002233_abnormal_nose_morphology | 0.84464013 |
| 130 | MP0002086_abnormal_extraembryonic_tissu | 0.84324542 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.83572402 |
| 132 | MP0005174_abnormal_tail_pigmentation | 0.81865987 |
| 133 | MP0008877_abnormal_DNA_methylation | 0.80609284 |
| 134 | MP0002837_dystrophic_cardiac_calcinosis | 0.79266133 |
| 135 | MP0002177_abnormal_outer_ear | 0.78424367 |
| 136 | MP0002095_abnormal_skin_pigmentation | 0.78404226 |
| 137 | MP0003453_abnormal_keratinocyte_physiol | 0.78254620 |
| 138 | MP0001243_abnormal_dermal_layer | 0.77834723 |
| 139 | * MP0001672_abnormal_embryogenesis/_devel | 0.77699650 |
| 140 | * MP0005380_embryogenesis_phenotype | 0.77699650 |
| 141 | MP0002060_abnormal_skin_morphology | 0.76734852 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.76720974 |
| 143 | MP0000703_abnormal_thymus_morphology | 0.76525711 |
| 144 | MP0004197_abnormal_fetal_growth/weight/ | 0.75873304 |
| 145 | MP0004215_abnormal_myocardial_fiber | 0.74898472 |
| 146 | MP0004147_increased_porphyrin_level | 0.74861729 |
| 147 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72720208 |
| 148 | * MP0000313_abnormal_cell_death | 0.72180795 |
| 149 | MP0000627_abnormal_mammary_gland | 0.71042780 |
| 150 | MP0001216_abnormal_epidermal_layer | 0.70523868 |
| 151 | * MP0000598_abnormal_liver_morphology | 0.70187645 |
| 152 | MP0000569_abnormal_digit_pigmentation | 0.70023500 |
| 153 | MP0010030_abnormal_orbit_morphology | 0.69723434 |
| 154 | MP0003795_abnormal_bone_structure | 0.69714527 |
| 155 | MP0003646_muscle_fatigue | 0.69604028 |
| 156 | MP0003868_abnormal_feces_composition | 0.69280891 |
| 157 | MP0003935_abnormal_craniofacial_develop | 0.68333649 |
| 158 | MP0003385_abnormal_body_wall | 0.68047459 |
| 159 | MP0003279_aneurysm | 0.67769561 |
| 160 | MP0005076_abnormal_cell_differentiation | 0.67744691 |
| 161 | MP0001849_ear_inflammation | 0.66947572 |
| 162 | MP0001186_pigmentation_phenotype | 0.65648958 |
| 163 | MP0000647_abnormal_sebaceous_gland | 0.65441872 |
| 164 | MP0002075_abnormal_coat/hair_pigmentati | 0.65378026 |
| 165 | MP0004084_abnormal_cardiac_muscle | 0.65185123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neoplasm of the adrenal cortex (HP:0100641) | 6.32258651 |
| 2 | Hepatoblastoma (HP:0002884) | 5.70865322 |
| 3 | Neonatal hypoglycemia (HP:0001998) | 5.33132034 |
| 4 | Diastasis recti (HP:0001540) | 5.21799273 |
| 5 | Abnormal pancreas size (HP:0012094) | 5.03482913 |
| 6 | Long foot (HP:0001833) | 4.84036122 |
| 7 | Reduced antithrombin III activity (HP:0001976) | 4.31328028 |
| 8 | Type I transferrin isoform profile (HP:0003642) | 4.07002576 |
| 9 | Acute myeloid leukemia (HP:0004808) | 3.73770015 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.64777547 |
| 11 | Abnormal protein glycosylation (HP:0012346) | 3.60774176 |
| 12 | Abnormal glycosylation (HP:0012345) | 3.60774176 |
| 13 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.60774176 |
| 14 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.60774176 |
| 15 | Neoplasm of the adrenal gland (HP:0100631) | 3.52297534 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.51600255 |
| 17 | Deep philtrum (HP:0002002) | 3.44503085 |
| 18 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.41889530 |
| 19 | Abnormal glucose tolerance (HP:0001952) | 3.32504193 |
| 20 | Abnormality of glycolysis (HP:0004366) | 3.32479037 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.24125709 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.16021275 |
| 23 | Multiple enchondromatosis (HP:0005701) | 3.12316486 |
| 24 | Chromsome breakage (HP:0040012) | 3.06813767 |
| 25 | Increased serum pyruvate (HP:0003542) | 3.04864501 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.01399064 |
| 27 | Myositis (HP:0100614) | 2.82006458 |
| 28 | Meckel diverticulum (HP:0002245) | 2.76571283 |
| 29 | Secondary amenorrhea (HP:0000869) | 2.75930624 |
| 30 | Abnormality of the ileum (HP:0001549) | 2.75314065 |
| 31 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.71717855 |
| 32 | Abnormality of the preputium (HP:0100587) | 2.70845683 |
| 33 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.70223232 |
| 34 | High anterior hairline (HP:0009890) | 2.69943404 |
| 35 | Enlarged kidneys (HP:0000105) | 2.66706506 |
| 36 | Orchitis (HP:0100796) | 2.65994692 |
| 37 | Abnormality of chromosome stability (HP:0003220) | 2.62825616 |
| 38 | White forelock (HP:0002211) | 2.58353952 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 2.57600922 |
| 40 | Cholecystitis (HP:0001082) | 2.57600922 |
| 41 | Embryonal renal neoplasm (HP:0011794) | 2.54181287 |
| 42 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.52231003 |
| 43 | Osteolytic defects of the hand bones (HP:0009699) | 2.52231003 |
| 44 | Abnormality of the umbilical cord (HP:0010881) | 2.45921712 |
| 45 | Thrombocytosis (HP:0001894) | 2.43247086 |
| 46 | Shoulder girdle muscle weakness (HP:0003547) | 2.42787741 |
| 47 | Overgrowth (HP:0001548) | 2.42759847 |
| 48 | Optic neuritis (HP:0100653) | 2.40718186 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.40718186 |
| 50 | Volvulus (HP:0002580) | 2.40340224 |
| 51 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.38952932 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.38884916 |
| 53 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.38217713 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36629402 |
| 55 | Squamous cell carcinoma (HP:0002860) | 2.35637535 |
| 56 | Birth length less than 3rd percentile (HP:0003561) | 2.33984842 |
| 57 | Cutaneous melanoma (HP:0012056) | 2.30549916 |
| 58 | Poor head control (HP:0002421) | 2.29802899 |
| 59 | Delayed gross motor development (HP:0002194) | 2.29333102 |
| 60 | Ependymoma (HP:0002888) | 2.27835949 |
| 61 | Sensory axonal neuropathy (HP:0003390) | 2.27778862 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.27371613 |
| 63 | Recurrent viral infections (HP:0004429) | 2.26340652 |
| 64 | Trismus (HP:0000211) | 2.23005593 |
| 65 | Degeneration of anterior horn cells (HP:0002398) | 2.21245816 |
| 66 | Abnormality of the anterior horn cell (HP:0006802) | 2.21245816 |
| 67 | Facial cleft (HP:0002006) | 2.20830923 |
| 68 | Prostate neoplasm (HP:0100787) | 2.17739923 |
| 69 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.17391654 |
| 70 | Single umbilical artery (HP:0001195) | 2.17391654 |
| 71 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.17391654 |
| 72 | 11 pairs of ribs (HP:0000878) | 2.16188571 |
| 73 | Progressive external ophthalmoplegia (HP:0000590) | 2.11294709 |
| 74 | Premature ovarian failure (HP:0008209) | 2.10813274 |
| 75 | Prolonged partial thromboplastin time (HP:0003645) | 2.10424225 |
| 76 | Intestinal atresia (HP:0011100) | 2.09919944 |
| 77 | Small intestinal stenosis (HP:0012848) | 2.09603093 |
| 78 | Duodenal stenosis (HP:0100867) | 2.09603093 |
| 79 | Progressive muscle weakness (HP:0003323) | 2.09573633 |
| 80 | Cortical dysplasia (HP:0002539) | 2.09381031 |
| 81 | Spastic diplegia (HP:0001264) | 2.08385191 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.07250304 |
| 83 | Postnatal microcephaly (HP:0005484) | 2.06407956 |
| 84 | Hypoplasia of the pons (HP:0012110) | 2.05229694 |
| 85 | Recurrent fungal infections (HP:0002841) | 2.04927156 |
| 86 | Advanced eruption of teeth (HP:0006288) | 2.03574971 |
| 87 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03381618 |
| 88 | Spontaneous hematomas (HP:0007420) | 2.02511147 |
| 89 | Spinal muscular atrophy (HP:0007269) | 2.02171242 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.01840591 |
| 91 | Natal tooth (HP:0000695) | 2.00311979 |
| 92 | Carpal bone hypoplasia (HP:0001498) | 2.00094446 |
| 93 | Pustule (HP:0200039) | 1.98053808 |
| 94 | Microvesicular hepatic steatosis (HP:0001414) | 1.97333135 |
| 95 | Abnormality of the pons (HP:0007361) | 1.97204024 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 1.95967752 |
| 97 | Abnormality of the duodenum (HP:0002246) | 1.95906201 |
| 98 | Abnormality of placental membranes (HP:0011409) | 1.95464519 |
| 99 | Amniotic constriction ring (HP:0009775) | 1.95464519 |
| 100 | Gonadotropin excess (HP:0000837) | 1.94017589 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 1.93885878 |
| 102 | Germ cell neoplasia (HP:0100728) | 1.90029169 |
| 103 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.89643058 |
| 104 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.89643058 |
| 105 | Septate vagina (HP:0001153) | 1.89462658 |
| 106 | Abnormality of the fingertips (HP:0001211) | 1.89357660 |
| 107 | Eosinophilia (HP:0001880) | 1.88297589 |
| 108 | Muscle fiber splitting (HP:0003555) | 1.87963979 |
| 109 | Rimmed vacuoles (HP:0003805) | 1.85573277 |
| 110 | Horseshoe kidney (HP:0000085) | 1.85325338 |
| 111 | Breast hypoplasia (HP:0003187) | 1.84278400 |
| 112 | Abnormal foot bone ossification (HP:0010675) | 1.83631681 |
| 113 | Abnormality of the prostate (HP:0008775) | 1.83523332 |
| 114 | Petechiae (HP:0000967) | 1.83445649 |
| 115 | Cellulitis (HP:0100658) | 1.82803688 |
| 116 | Long clavicles (HP:0000890) | 1.81669505 |
| 117 | Abnormal tarsal ossification (HP:0008369) | 1.80749243 |
| 118 | Progressive inability to walk (HP:0002505) | 1.80357931 |
| 119 | Nonimmune hydrops fetalis (HP:0001790) | 1.80011573 |
| 120 | Genu varum (HP:0002970) | 1.79918630 |
| 121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.79633312 |
| 122 | Abnormality of DNA repair (HP:0003254) | 1.79468868 |
| 123 | Nausea (HP:0002018) | 1.79166970 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 1.79090530 |
| 125 | Popliteal pterygium (HP:0009756) | 1.78952668 |
| 126 | Abnormality of the intrinsic pathway (HP:0010989) | 1.77932188 |
| 127 | Keratoconjunctivitis (HP:0001096) | 1.77850522 |
| 128 | Poikiloderma (HP:0001029) | 1.77413140 |
| 129 | Resting tremor (HP:0002322) | 1.77237054 |
| 130 | Tetraparesis (HP:0002273) | 1.77013927 |
| 131 | IgA deficiency (HP:0002720) | 1.76833595 |
| 132 | Nemaline bodies (HP:0003798) | 1.76167647 |
| 133 | Gastrointestinal infarctions (HP:0005244) | 1.75726797 |
| 134 | Cervical subluxation (HP:0003308) | 1.75517914 |
| 135 | Obstructive lung disease (HP:0006536) | 1.75228284 |
| 136 | Chronic obstructive pulmonary disease (HP:0006510) | 1.75228284 |
| 137 | Upper motor neuron abnormality (HP:0002127) | 1.75145315 |
| 138 | Vasculitis (HP:0002633) | 1.75131442 |
| 139 | Choanal atresia (HP:0000453) | 1.74870117 |
| 140 | Absent thumb (HP:0009777) | 1.74843315 |
| 141 | Ectopic kidney (HP:0000086) | 1.73892854 |
| 142 | Astrocytoma (HP:0009592) | 1.73158643 |
| 143 | Abnormality of the astrocytes (HP:0100707) | 1.73158643 |
| 144 | Flat capital femoral epiphysis (HP:0003370) | 1.72211027 |
| 145 | Osteomyelitis (HP:0002754) | 1.71240077 |
| 146 | Leukocytosis (HP:0001974) | 1.71110010 |
| 147 | Partial agenesis of the corpus callosum (HP:0001338) | 1.70510010 |
| 148 | Sloping forehead (HP:0000340) | 1.70507505 |
| 149 | Tongue fasciculations (HP:0001308) | 1.70248738 |
| 150 | Horizontal nystagmus (HP:0000666) | 1.69804106 |
| 151 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.69246964 |
| 152 | Recurrent pneumonia (HP:0006532) | 1.69055163 |
| 153 | Proximal tubulopathy (HP:0000114) | 1.69001719 |
| 154 | Granulocytopenia (HP:0001913) | 1.68641821 |
| 155 | Aplasia cutis congenita (HP:0001057) | 1.67538035 |
| 156 | Recurrent skin infections (HP:0001581) | 1.66578838 |
| 157 | Vertebral compression fractures (HP:0002953) | 1.66121510 |
| 158 | Short nail (HP:0001799) | 1.65576819 |
| 159 | Systemic lupus erythematosus (HP:0002725) | 1.64833284 |
| 160 | Clubbing of toes (HP:0100760) | 1.64703144 |
| 161 | Entropion (HP:0000621) | 1.64309624 |
| 162 | Neoplasm of the liver (HP:0002896) | 1.64236371 |
| 163 | Basal ganglia calcification (HP:0002135) | 1.64151497 |
| 164 | IgM deficiency (HP:0002850) | 1.63983103 |
| 165 | Albinism (HP:0001022) | 1.63600860 |
| 166 | Abnormal lung lobation (HP:0002101) | 1.63059497 |
| 167 | Abnormal hair whorl (HP:0010721) | 1.62367429 |
| 168 | Spinal cord lesions (HP:0100561) | 1.62284429 |
| 169 | Syringomyelia (HP:0003396) | 1.62284429 |
| 170 | Microglossia (HP:0000171) | 1.62098543 |
| 171 | Arterial thrombosis (HP:0004420) | 1.59511432 |
| 172 | Large hands (HP:0001176) | 1.58759730 |
| 173 | Abnormal gallbladder morphology (HP:0012437) | 1.58527909 |
| 174 | Submucous cleft hard palate (HP:0000176) | 1.58359724 |
| 175 | Rough bone trabeculation (HP:0100670) | 1.58164499 |
| 176 | Encephalitis (HP:0002383) | 1.58038279 |
| 177 | Hyperglycemia (HP:0003074) | 1.57064712 |
| 178 | Agnosia (HP:0010524) | 1.56943032 |
| 179 | Anorexia (HP:0002039) | 1.55147525 |
| 180 | Asymmetry of the thorax (HP:0001555) | 1.54302589 |
| 181 | Narrow palate (HP:0000189) | 1.53094704 |
| 182 | Pulmonary infiltrates (HP:0002113) | 1.51682903 |
| 183 | Premature rupture of membranes (HP:0001788) | 1.51394013 |
| 184 | Gingivitis (HP:0000230) | 1.51265005 |
| 185 | Myelodysplasia (HP:0002863) | 1.50560850 |
| 186 | Myocardial infarction (HP:0001658) | 1.50406764 |
| 187 | Abnormality of T cells (HP:0002843) | 1.49900033 |
| 188 | Patchy hypopigmentation of hair (HP:0011365) | 1.48711515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRSK2 | 3.69221015 |
| 2 | STK16 | 3.04877946 |
| 3 | TRIM28 | 2.93819221 |
| 4 | NEK1 | 2.92283052 |
| 5 | PBK | 2.73731536 |
| 6 | PNCK | 2.23686834 |
| 7 | BUB1 | 2.22761893 |
| 8 | PRKG2 | 2.22757226 |
| 9 | PDK2 | 2.21593491 |
| 10 | EIF2AK1 | 2.13549872 |
| 11 | MKNK2 | 2.13475921 |
| 12 | WEE1 | 2.07594411 |
| 13 | STK24 | 1.94755969 |
| 14 | PIM2 | 1.92867399 |
| 15 | MAP3K14 | 1.90103243 |
| 16 | ZAK | 1.88550639 |
| 17 | PLK4 | 1.76701197 |
| 18 | MAP3K3 | 1.76309582 |
| 19 | MKNK1 | 1.73478936 |
| 20 | STK3 | 1.73305622 |
| 21 | STK10 | 1.71201355 |
| 22 | NEK9 | 1.67703722 |
| 23 | MAP2K3 | 1.66381579 |
| 24 | TYK2 | 1.64139444 |
| 25 | BRSK1 | 1.60083533 |
| 26 | TRPM7 | 1.47881910 |
| 27 | JAK3 | 1.42563298 |
| 28 | MET | 1.42339363 |
| 29 | MAP4K1 | 1.41510787 |
| 30 | NUAK1 | 1.38821174 |
| 31 | BRD4 | 1.38255001 |
| 32 | IRAK4 | 1.34475421 |
| 33 | TXK | 1.34376594 |
| 34 | TEC | 1.33565951 |
| 35 | ERBB4 | 1.31641454 |
| 36 | NME1 | 1.27169448 |
| 37 | EIF2AK3 | 1.26462686 |
| 38 | FRK | 1.26443138 |
| 39 | CDK8 | 1.26325737 |
| 40 | CDC7 | 1.24878694 |
| 41 | BMPR1B | 1.22166456 |
| 42 | RPS6KA4 | 1.18357632 |
| 43 | EPHA3 | 1.16173769 |
| 44 | MAPKAPK3 | 1.14355716 |
| 45 | STK4 | 1.12879149 |
| 46 | ERN1 | 1.12845225 |
| 47 | ZAP70 | 1.12798597 |
| 48 | ERBB3 | 1.10588487 |
| 49 | MARK3 | 1.10474307 |
| 50 | NME2 | 1.10307487 |
| 51 | TBK1 | 1.07897412 |
| 52 | PIM1 | 1.07734855 |
| 53 | TSSK6 | 1.06567704 |
| 54 | IRAK3 | 1.06114957 |
| 55 | CCNB1 | 1.05930286 |
| 56 | TESK1 | 1.05903346 |
| 57 | OBSCN | 1.05179428 |
| 58 | CHUK | 1.04340750 |
| 59 | BTK | 1.04318519 |
| 60 | EPHB1 | 1.04221640 |
| 61 | RIPK1 | 1.03489471 |
| 62 | EIF2AK2 | 1.03331640 |
| 63 | PLK3 | 1.01843635 |
| 64 | IKBKB | 1.00560321 |
| 65 | SRPK1 | 0.97793300 |
| 66 | AURKB | 0.97361437 |
| 67 | NEK2 | 0.95572686 |
| 68 | NLK | 0.94960078 |
| 69 | * ATM | 0.94563509 |
| 70 | CHEK2 | 0.92601192 |
| 71 | EEF2K | 0.91812675 |
| 72 | MYLK | 0.90616286 |
| 73 | TGFBR2 | 0.88449708 |
| 74 | LATS2 | 0.87943628 |
| 75 | ITK | 0.85772812 |
| 76 | CAMK1G | 0.85353470 |
| 77 | CLK1 | 0.85007953 |
| 78 | PTK2 | 0.83875795 |
| 79 | TGFBR1 | 0.83701602 |
| 80 | BMPR2 | 0.83604687 |
| 81 | PIK3CG | 0.82637788 |
| 82 | PAK4 | 0.79736410 |
| 83 | IKBKE | 0.78555494 |
| 84 | STK38L | 0.78520552 |
| 85 | PLK1 | 0.78134306 |
| 86 | AKT3 | 0.78042727 |
| 87 | LATS1 | 0.77891803 |
| 88 | PLK2 | 0.76876825 |
| 89 | RAF1 | 0.74031572 |
| 90 | MAPKAPK2 | 0.72500136 |
| 91 | CSNK1G1 | 0.72431284 |
| 92 | MST4 | 0.70927803 |
| 93 | MST1R | 0.70445246 |
| 94 | PRKCI | 0.69695097 |
| 95 | CDK12 | 0.68563341 |
| 96 | JAK1 | 0.66636322 |
| 97 | TTK | 0.66222282 |
| 98 | WNK3 | 0.66174801 |
| 99 | KIT | 0.64730932 |
| 100 | FGFR1 | 0.63823297 |
| 101 | BLK | 0.63780924 |
| 102 | PASK | 0.63274074 |
| 103 | RPS6KB2 | 0.60030118 |
| 104 | FGFR3 | 0.57060697 |
| 105 | CDK4 | 0.56936835 |
| 106 | CDK6 | 0.56749786 |
| 107 | FLT3 | 0.56707801 |
| 108 | ATR | 0.56256320 |
| 109 | TAOK3 | 0.56094198 |
| 110 | AKT2 | 0.52812624 |
| 111 | CDK1 | 0.52347839 |
| 112 | TTN | 0.50762855 |
| 113 | TNIK | 0.50723006 |
| 114 | FER | 0.50343280 |
| 115 | FGFR4 | 0.50162019 |
| 116 | CDK7 | 0.49976264 |
| 117 | MAP3K12 | 0.47416250 |
| 118 | MAP3K8 | 0.47119062 |
| 119 | SIK3 | 0.47083503 |
| 120 | CDK2 | 0.46172868 |
| 121 | PAK2 | 0.45878088 |
| 122 | CHEK1 | 0.45432827 |
| 123 | ACVR1B | 0.44047042 |
| 124 | SCYL2 | 0.43915040 |
| 125 | LYN | 0.42719160 |
| 126 | CDK9 | 0.42654773 |
| 127 | FGR | 0.42363875 |
| 128 | VRK2 | 0.41983442 |
| 129 | DYRK3 | 0.41789915 |
| 130 | EPHA2 | 0.41622482 |
| 131 | CSF1R | 0.41188228 |
| 132 | RPS6KL1 | 0.40891066 |
| 133 | RPS6KC1 | 0.40891066 |
| 134 | CSNK2A2 | 0.40809490 |
| 135 | KSR1 | 0.40690169 |
| 136 | JAK2 | 0.40528913 |
| 137 | ROCK2 | 0.40169105 |
| 138 | SYK | 0.39785539 |
| 139 | SGK2 | 0.39609999 |
| 140 | CSNK1E | 0.39429991 |
| 141 | PAK1 | 0.39253568 |
| 142 | VRK1 | 0.39251570 |
| 143 | CSNK2A1 | 0.37953734 |
| 144 | GSK3A | 0.37779875 |
| 145 | AURKA | 0.36642792 |
| 146 | CSNK1G2 | 0.36571875 |
| 147 | ILK | 0.36461763 |
| 148 | CSNK1G3 | 0.36270694 |
| 149 | ALK | 0.35416598 |
| 150 | YES1 | 0.34690527 |
| 151 | * PRKDC | 0.34558177 |
| 152 | CSNK1A1L | 0.33504974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.46817478 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.17703221 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.15107482 |
| 4 | Cell cycle_Homo sapiens_hsa04110 | 2.11335616 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.06742033 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05492008 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.01992092 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00157246 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.96424097 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96342403 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 1.87246284 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85061615 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.83897013 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.76755615 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.75622522 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.73971677 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68236513 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68173197 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.65129804 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63455082 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.62258180 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61534045 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57394451 |
| 24 | RNA transport_Homo sapiens_hsa03013 | 1.47424739 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.46822624 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44627599 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.43805102 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40775608 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.40423760 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.40161614 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39669000 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37003615 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36862024 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36345620 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34244195 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 1.33405453 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.33292398 |
| 38 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.33033785 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.31381157 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29943964 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28186577 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27622263 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26663069 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25423998 |
| 45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21693739 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21559341 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21441255 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21049192 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18084183 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.17446228 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17295164 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 1.16881492 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.16685180 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16374092 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15436224 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15179542 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14948206 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14631398 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13041144 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 1.12606559 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.12566134 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12401017 |
| 63 | Spliceosome_Homo sapiens_hsa03040 | 1.11755263 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.10734118 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09050976 |
| 66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07686573 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03682097 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00031317 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99781659 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.98628664 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.96637465 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94429196 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94216894 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92974302 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.92715324 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92640497 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.92143075 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91751173 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90089383 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89904729 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89357080 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86752230 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86668612 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.86378848 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84935680 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.84895148 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83956519 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.83261717 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81583410 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77909464 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77251958 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77144334 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75948724 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75313082 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72843668 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72725946 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72714261 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72291033 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72216581 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70223846 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70106188 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69513134 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68284445 |
| 104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68142618 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.67855459 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67649354 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66747748 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65864887 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65337429 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64916452 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64911225 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.63784929 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.63599337 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62586007 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.62084073 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61087772 |
| 117 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61073861 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60679362 |
| 119 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60390040 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59503558 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59111097 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57403038 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57350637 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.56827067 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54944385 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54522477 |
| 127 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54170460 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51731838 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.51646736 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51111475 |
| 131 | Adherens junction_Homo sapiens_hsa04520 | 0.49415337 |
| 132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48955125 |
| 133 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47385349 |
| 134 | Purine metabolism_Homo sapiens_hsa00230 | 0.46858982 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45339503 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44386409 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44363543 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44190912 |
| 139 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43205921 |
| 140 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38623422 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38033916 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37510769 |
| 143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37316530 |
| 144 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36882546 |
| 145 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35581013 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33100367 |
| 147 | Bladder cancer_Homo sapiens_hsa05219 | 0.29203607 |
| 148 | Tight junction_Homo sapiens_hsa04530 | 0.25262913 |
| 149 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23807614 |
| 150 | Huntingtons disease_Homo sapiens_hsa05016 | 0.21272551 |
| 151 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.18323155 |
| 152 | Peroxisome_Homo sapiens_hsa04146 | 0.16447324 |
| 153 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.16298418 |

